2-Chloro-3-fluoro-5-nitropyridine | CAS:1079179-12-6

We serve 2-Chloro-3-fluoro-5-nitropyridine CAS:1079179-12-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Chloro-3-fluoro-5-nitropyridine

Chemical Name:    2-Chloro-3-fluoro-5-nitropyridine
CAS.NO: 1079179-12-6
Synonyms: 2-Chloro-3-fluoro-5-nitropyridine
Molecular Formula: C5H2ClFN2O2
Molecular Weight: 176.53300
 
Physical and Chemical Properties:
Density: 1.6±0.1 g/cm3
Melting point: /
Boiling point: 247.0±35.0 °C at 760 mmHg
Flash point: 103.2±25.9 °C
Index of Refraction: 1.560
 
Specification:
Appearance:White Crystalline Powder
Purity:≥99.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry
Application:   used in the Pharmaceutical intermediate



Contact us for information like 2-Chloro-3-fluoro-5-nitropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloro-3-fluoro-5-nitropyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Chloro-3-fluoro-5-nitropyridine Use and application,2-Chloro-3-fluoro-5-nitropyridine technical grade,usp/ep/jp grade.


Related News: The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island.2-Methylphenyl isothiocyanate manufacturer The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.3-trimethoxysilylpropyl acetate supplier The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.Diallylamine vendor Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.